655 results on '"Mancini I."'
Search Results
2. Use of carbon materials for produced water treatment: a review on adsorption process and performance
3. OC 42.2 Incidence and Risk Factors of Major Adverse Cardiovascular Events in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura during Remission
4. PB0313 Towards the Standardisation of ADAMTS-13 Antibody Testing in Thrombotic Thrombocytopenic Purpura (TTP)-Results of the IMATAS Collaborative Study
5. PB0333 Therapeutic Plasma Exchange-Related Complications in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
6. PB0321 Prospective Evaluation of the HemosIL AcuStar ADAMTS13 Activity Assay
7. OC 26.3 Main Features of Ischemic Stroke in Patients with Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura
8. PB0316 Bortezomib for the Treatment of Multi-Refractory Immune-Mediated Thrombotic Thrombocytopenic Purpura: An Italian Multicenter Survey
9. PB0027 Assessing Genetic Risk Factors for Early-Onset Coronary Artery Disease in Iranians
10. OC 42.3 Immune-Mediated TTP Patients in Remission with Recovered ADAMTS13 Activity but an Open ADAMTS13 Conformation are at Risk for Earlier ADAMTS13 Relapse
11. Vibrational properties of inclusion complexes: the case of indomethacin-cyclodextrin
12. Quantification of CO2 and N2O Emissions from a Pilot-Scale Aerobic Digester, Towards the Validation and Calibration of the First Activated Sludge Model for Aerobic Digestion (AeDM1)
13. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura
14. Introduction: Understanding the EU as a good global actor: whose metrics?
15. Test-positive rate at CT colonography is increased by rectal bleeding and/or unexplained weight loss, unlike other common gastrointestinal symptoms
16. Measurement and prevalence of circulating ADAMTS13‐specific immune complexes in autoimmune thrombotic thrombocytopenic purpura
17. The ISTH Bleeding Assessment Tool and the risk of future bleeding
18. Photo-enzymatic dityrosine crosslinking for bioprinting
19. ADAMTS‐13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
20. Burrows-Wheeler Transform on Purely Morphic Words
21. Additional file 1 of Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
22. Labour rights protection in EU trade agreements: can trade agreements 'only do so much'?
23. The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age
24. T-dependence of the vibrational dynamics of IBP/diME-β-CD in solid state: A FT-IR spectral and quantum chemical study
25. VP01.04: Anamnestic and ultrasonographic factors associated with enhanced myometrial vascularity: preliminary data from a cohort study
26. Pharmacological inactivation of the prion protein by targeting a folding intermediate
27. Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
28. Nuove frontiere nella chirurgia oncologica dell’apparato muscolo-scheletrico
29. Ricostruzioni pericotiloidee utilizzando trapianti massivi
30. Metabolite profile of marine-derived endophytic Streptomyces sundarbansensis WR1L1S8 by liquid chromatography-mass spectrometry and evaluation of culture conditions on antibacterial activity and mycelial growth
31. Fundamental Rights in the EU’s External Trade Relations: From Promotion ‘Through’ Trade Agreements to Protection ‘in’ Trade Agreements
32. What biotic indices tell us about ecosystem change: lessons from the seagrass Posidonia oceanica
33. Deepening Trade and Fundamental Rights? Harnessing Data Protection Rights in the Regulatory Cooperation Chapters of EU Trade Agreements
34. WHAT BIOTIC INDICES TELL US ABOUT ECOSYSTEM CHANGE: LESSONS FROM THE SEAGRASS POSIDONIA OCEANICA INDICES APPLICATION ON HISTORICAL DATA
35. The EU as an Intentional or Accidental Convergence Actor? Learning from the EU-Japan Data Adequacy Negotiations
36. Fundamental rights in the institutional architecture of EU trade agreements: a tale of omissions
37. The EU as a Good Global Actor
38. Evaluation of articular cartilage with quantitative MRI in an equine model of post‐traumatic osteoarthritis
39. International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13
40. A composite hydrogel-3D printed thermoplast osteochondral anchor as example for a zonal approach to cartilage repair: In vivo performance in a long-term equine model
41. FRET rather than CBA reflects ADAMTS13 proteolytic activity in thrombotic thrombocytopenic purpura patients with discordant measurements: PB 3.33–4
42. Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura: PA 4.19–2
43. Bisphosphonates for cancer patients: why, how, and when?
44. Supportive and palliative care: experience at the Institut Jules Bordet
45. Preformed homologous cortical bone prostheses for ossiculoplasty: preliminary clinical results in eighteen patients
46. Measurement of anti-ADAMTS13 neutralizing autoantibodies: a comparison between CBA and FRET assays
47. Assessment of dyspnea in advanced cancer patients
48. EFFECT OF BETA-SITOSTEROL IN PRO-INFLAMMATORY GENE EXPRESSION IN BRONCHIAL EPITHELIAL CELLS: 227
49. A composite hydrogel-3D printed thermoplast osteochondral anchor as example for a zonal approach to cartilage repair: in vivo performance in a long-term equine model
50. Corrigendum to “The pre-analytical phase of liquid biopsy” [New Biotechnol. 55, 25 March 2020, 19–29]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.